EMEA – FDA – EUROPEAN COMMISSION – CONFIDENTIALITY AGREEMENT EXTENSION
December 1st, 2005
BY KEITH NUTHALL
THE CONFIDENTIALITY agreement signed in 2003 between the European Commission, the European Medicines Agency (EMEA) and the US Food and Drug Administration will be extended another five years to 2010. This follows "positive experience gained" from the initial deal, which allows the parties to exchange information during their mutual regulatory duties.
THE CONFIDENTIALITY agreement signed in 2003 between the European Commission, the European Medicines Agency (EMEA) and the US Food and Drug Administration will be extended another five years to 2010. This follows "positive experience gained" from the initial deal, which allows the parties to exchange information during their mutual regulatory duties.
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.